Lumida
/BIOA
⌘K
BIOAGE Labs Inc

BIOAGE Labs Inc

BIOA
$8.49USD-1.85%-0.16 today

MARKET CAP

389.7M

P/E (TTM)

FWD P/E

DAY RANGE

$8 – $9

52W RANGE

$5
$26

AI Summary

Stalk
StalkMedium

Despite a durable long-term uptrend above the 200-day SMA, the recent Bullish Exhaustion pattern and rejection below the 9-/20-day EMAs signal waning upside momentum. With Extreme OS range status granting mean-reversion permission, the medium-term bias remains bullish, but execution should be deferred until a pullback into the rising 50-day SMA is absorbed and signs of renewed demand appear.

  • Q2 2026 loss of $0.58/sh beat $0.65 estimate; collaboration revenue flat at $2.5M YoY
  • Cash reserves of $381.3M support R&D runway through 2029
  • Q2 2026 net loss of $26.1M widened from $21.6M YoY; R&D spend at $24.4M strains cash
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2025TREND
Sales, Adj.$9.0M
YoY %
P / Sales52.9x
EV / Sales34.4x
Gross Profit, Adj.$9.0M
YoY %
Margin %100.0%
EV / Gross Profit34.4x
EBITDA, Adj.$-92.6M
YoY %-18.6%
Margin %-1029.1%
EV / EBITDA-3.3x
EBIT$-92.8M
YoY %-18.7%
Margin %-1031.5%
EV / EBIT-3.3x
Net Income$-80.6M
YoY %-13.4%
Net Margin-896.1%
EPS (GAAP)-$2.24
YoY %+66.2%